Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

PLANNING SOCIAL MEDIA CAMPAIGNS – THE HEALTHCARE MARKETER’S GUIDE

Social media channels are now a key part of how brands and audiences connect and communicate. Audiences are no longer passive recipients to brand messaging; two-way communication is an expectation...

IGNIFI

- PMLiVE

Pfizer/BioNTech’s Omicron JN.1-adapted COVID-19 vaccine approved by MHRA

The UK regulator has approved four versions of the updated vaccine for adults and children from infancy

- PMLiVE

Merck’s Keytruda combination recommended by NICE for advanced gastric cancer

More than 6,500 new cases of gastric cancer are diagnosed in the UK every year

- PMLiVE

Study reveals GSK’s new recombinant shingles vaccine could reduce dementia risk

Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years

- PMLiVE

Johnson & Johnson’s Rybrevant recommended by CHMP for pre-treated advanced NSCLC

Non-small lung cancer accounts for up to 85% of all lung cancer cases

- PMLiVE

Creativity at Cannes Lions 2024

Across almost every sector, brands are multiplying their investment in creativity

- PMLiVE

AstraZeneca signs exclusive licensing deal worth over $500m for Pinetree’s EGFR degrader

The candidate has shown promising preclinical anti-tumour activity in drug- and TKI-resistant tumours

- PMLiVE

Pfizer’s one-time haemophilia B gene therapy Durveqtix granted EC approval

More than 42,000 people globally are living with the rare bleeding disorder

- PMLiVE

AbbVie’s IL-23 inhibitor Skyrizi approved by EC to treat ulcerative colitis in adults

The form of inflammatory bowel disease is estimated to affect five million people globally

- PMLiVE

Ipsen gains ex-US rights to Day One’s brain cancer therapy in deal worth over $460m

Paediatric low-grade gliomas are the most common type of brain tumour diagnosed in children

- PMLiVE

Boehringer Ingelheim’s Metalyse recommended by NICE to treat stroke in adults

Ischaemic stroke is responsible for around 85% of all stroke cases in the UK

- PMLiVE

Bayer’s octopus move

The evolutionary lessons for Bayer’s management restructure

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links